Armata Pharmaceuticals, Inc.
ARMP
$9.00
$0.182.04%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -365.97% | -63.70% | -149.50% | -351.19% | 147.44% |
| Total Depreciation and Amortization | 12.97% | 1.09% | -2.92% | -0.79% | 21.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 480.59% | 88.47% | 4,778.60% | 98.11% | -338.26% |
| Change in Net Operating Assets | -101.82% | 190.88% | -66.75% | -200.67% | 227.17% |
| Cash from Operations | -55.28% | 40.40% | 4.87% | 4.38% | 10.56% |
| Capital Expenditure | 78.51% | -62.42% | -50.51% | -228.57% | 122.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.51% | -62.42% | -50.51% | -228.57% | 122.65% |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.60% | -- | -100.00% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.19% | 241.68% | -419.03% | 129.39% | 15.26% |